johnson & johnson recalls tylenol, rolaids and motrin over bad odor - best air purifier for mold and mildew

Johnson & Johnson is recalling batches from some big businesses. selling, over-the-
After the customer complained that the packaging had the smell of mold and mold, the counter medicine.
The affected products include a variety of Tylenol and motlin painkillers, Rolaids antacids, St.
Aspirin and benajo anti-allergic tablets.
Not every bottle of medicine needs to be thrown away or returned.
J & J's McNeil division has compiled a complete list of medicines, and the company says consumers should avoid buying them here.
In a statement, the company said "a small number of cases" appeared after taking the drug, and people had temporary stomach problems, including nausea and vomiting.
The health problem is"
"Serious," said J & J.
The recall expanded the actions taken over the past two months to address certain Tylenol odor issues and now affects most of the company's best productsknown brands. What's going on?
J & J says the smell comes from a chemical called 2,6-
Isole tribromo ether, tbd.
The source of smelly things may be another kind of decomposition of chemicals used to handle the wood in transport pallets.
A spokeswoman for Johnson & Johnson told us that the company had told suppliers to stop using treated wood in pallets, packing materials loaded with medicines in pallets.
Update: The Food and Drug Administration is very dissatisfied with Johnson & Johnson's handling of the issue.
In a phone call with reporters, an intermediary official said that the company "became aware of the issue in September 2008 and that it was not until about a year later that they began investigating and reporting to the intermediary, we thought we would act faster than that.
"The FDA issued a formal warning to the company on Friday, claiming it violated the government's quality rules.
During a government inspection at a factory in Puerto Rico, the findings were encouraging.
The agency concluded that Johnson & Johnson's "preliminary investigation into the root cause of the odor was delayed without reason and terminated prematurely.
"In the four months of 2008, many complaints came before the company discovered trends and set out to find out the cause of the problem.
The FDA said bluntly, "neither Johnson & Johnson nor the top management of McNeil's consumer health care company has a guarantee to investigate and solve these problems in a timely manner.
"Johnson & Johnson has 15 working days to tell the FDA how it will address these issues.